Somebody switched the price tags on what is truly valuable
In Geneva, the World Health Organization stood before its annual assembly not merely to present a budget, but to argue for its own continued existence. The United States' withdrawal of funding under President Trump has torn a $1.7 billion hole in the agency's finances, forcing a 22 percent reduction in planned spending and threatening health operations across 150 countries. Director-General Tedros Adhanom Ghebreyesus reframed the $2.1 billion annual request against the world's military expenditures and tobacco advertising budgets, asking a fundamental question about what humanity chooses to value. The crisis is not only financial — it is a test of whether multilateral institutions built on shared purpose can endure in an age of resurgent nationalism.
- A $1.7 billion funding gap, triggered by the U.S. withdrawal and compounded by European nations quietly reducing their own contributions, has left WHO able to fund only 60 percent of its already-slashed revised budget.
- Experts warn the hollowing out of pandemic preparedness and disease surveillance could cost millions of lives — not as abstraction, but as a foreseeable consequence of decisions being made right now in assembly halls and finance ministries.
- Some wealthy nations have used American withdrawal as political cover to cut their own aid, turning a bilateral rupture into a cascading multilateral retreat from global health commitments.
- WHO is attempting to stabilize itself through a 20 percent increase in mandatory member dues and a landmark pandemic treaty designed to ensure equitable access to vaccines and medicines — but neither carries enforcement teeth.
- Inside the organization, restructuring is already underway: senior leadership departures, a salary gap exceeding $500 million, and an institution of nearly 80 years now openly fighting for its relevance and survival.
On Monday in Geneva, WHO Director-General Tedros Adhanom Ghebreyesus addressed the agency's annual assembly with an appeal that was equal parts budget request and existential argument. He was asking member nations to fund a $2.1 billion annual budget — a figure he called "extremely modest" — but the room had changed. Since January, the United States, historically WHO's largest donor, had cut off its funding under a Trump executive order, leaving a $1.7 billion gap and forcing the agency to reduce its planned two-year budget by 22 percent. Even after that reduction, only about 60 percent of the revised budget has been secured.
To make the number legible, Tedros reframed it: $2.1 billion is what the world spends on its militaries every eight hours. It is the price of one stealth bomber. It is a quarter of what the tobacco industry spends annually advertising a product that kills. "It seems somebody switched the price tags on what is truly valuable in our world," he said — a deliberate attempt to expose the gap between stated priorities and actual spending choices.
The financial crisis has already begun to erode WHO's capacity to function across its 150-country mandate, which spans pandemic response, disease surveillance, and public health guidance. Compounding the U.S. withdrawal, several European nations have quietly reduced their own contributions, redirecting funds toward defense amid the war in Ukraine. Georgetown's Matthew Kavanagh warned that some countries have used American withdrawal as political cover for their own retreats, and that WHO now faces something beyond a budget problem — a fundamental question about whether multilateral institutions can survive rising nationalism. "Literally millions will likely die needlessly on the current trajectory," he said.
The assembly is weighing two potential lifelines: a 20 percent increase in mandatory member dues, which would reduce dependence on volatile voluntary funding, and a pandemic treaty years in the making, designed to ensure equitable global access to vaccines and medicines in future outbreaks. Kavanagh suggested the treaty's passage could signal that global health cooperation might advance even without Washington. But both measures carry significant uncertainty — the treaty has no enforcement mechanisms, and the absence of the United States, which drove much of COVID-19 vaccine development, raises real questions about its practical reach.
Outside the Geneva compound, protesters from CitizenGo demonstrated against the treaty, framing it as a power grab by globalist elites. Inside, Tedros announced a management restructuring that includes the departure of emergencies chief Dr. Michael Ryan, as the organization scrambles to cut costs. With a salary gap exceeding $500 million and its founding mission under political siege, WHO now faces a vote not just on dues and treaties, but on whether the world still believes a shared institution for global health is worth sustaining.
In Geneva on Monday, the head of the World Health Organization stood before the agency's annual assembly and made his case for survival in the starkest terms he could manage. Tedros Adhanom Ghebreyesus, the organization's director-general, was asking member countries to fund a $2.1 billion annual budget—a sum he described as "extremely modest"—but he knew the ask was landing in a room where the math had suddenly shifted. The United States, historically WHO's largest donor, had cut off its funding in January under President Donald Trump's executive order. The agency was now operating in a state of acute financial crisis, and Ghebreyesus needed to make people understand what was actually at stake.
He did this by reframing the number. Two-point-one billion dollars, he told the assembly, equals the world's military spending every eight hours. It is the cost of a single stealth bomber. It is one-quarter of what the tobacco industry spends annually on advertising—for a product that kills people. "It seems somebody switched the price tags on what is truly valuable in our world," he said. The rhetorical move was deliberate: strip away the abstraction of a budget line and show what the world actually chooses to spend money on, and what it refuses to.
The numbers behind the crisis are stark. WHO had originally planned a budget for the next two years, but has now reduced it by 22 percent in response to the U.S. withdrawal and cuts from other wealthy nations. Even with that drastic reduction, the agency has secured commitments for only about 60 percent of the revised budget. This leaves a gap of $1.7 billion—money the organization says it needs to continue operations in 150 countries across its vast mandate, which ranges from pandemic response to disease surveillance to public health guidance. Tedros acknowledged the challenge of closing that gap in the current climate, but he pushed back against the notion that the request was unreasonable. For an organization of WHO's scope and reach, he said, $2.1 billion annually is not ambitious. It is the bare minimum.
The funding crisis has already begun to hollow out the agency's capacity. WHO has seen its ability to execute its mandate plummet. The organization is grappling not only with the U.S. pullout but also with reduced contributions from wealthy European countries, many of which are redirecting resources toward defense spending in response to Russian aggression. Matthew Kavanagh, director of Georgetown University's Center for Global Health Policy and Politics, observed that some nations have used the American withdrawal as political cover to reduce their own aid commitments. He warned that WHO now faces what amounts to an existential crisis—not merely a budget problem, but a fundamental question about whether multilateral institutions can function in an era of rising nationalism and information warfare. "Literally millions will likely die needlessly on the current trajectory," Kavanagh said, "and the world's health ministers do not seem capable of a coherent response."
The assembly is also considering two major initiatives aimed at stabilizing WHO's future. Member countries are expected to approve a 20 percent increase in assessed contributions—the mandatory dues that countries pay to the organization—which would reduce reliance on voluntary funding that fluctuates year to year. They are also poised to adopt a pandemic treaty, the product of years of negotiation, designed to prevent a repeat of the fragmented and unequal response to COVID-19. The treaty would guarantee that countries sharing virus samples receive access to resulting tests, medicines, and vaccines, and would allocate up to 20 percent of such products to WHO for distribution to poorer nations. Kavanagh suggested that passage of the treaty could represent a significant victory—evidence that global health cooperation might survive and even advance without U.S. participation.
Yet significant doubts shadow both initiatives. The treaty carries no enforcement mechanisms; countries that ignore it face no penalties, a common weakness in international agreements. And the absence of the United States—which invested billions in vaccine development during COVID-19—raises questions about the treaty's real-world effectiveness. Trump has long criticized WHO, first withdrawing the U.S. during his first term over allegations that the organization was too deferential to China and mishandled the pandemic response. President Biden reversed that decision, but Trump's return to office has brought the withdrawal back. The formal pullout is scheduled for next January, following a one-year notification period required by U.S. law.
Opposition to WHO extends beyond the Trump administration. Outside the Geneva compound where the assembly convened, the activist group CitizenGo protested the pandemic treaty, displaying a balloon sculpture of the world and a banner attacking "globalist elites" while depicting Tedros and Bill Gates, a major WHO philanthropic supporter, shaking hands surrounded by dollar signs. The group's campaigner Sebastian Lukomski accused WHO of seeking to "centralize even more power" and remove fundamental freedoms in the wake of COVID-19. Meanwhile, inside the organization, Tedros has announced a management restructuring that includes the departure of Dr. Michael Ryan, the emergencies chief, as WHO attempts to cut costs and adapt to its new financial reality. The organization faces a salary gap exceeding $500 million. What happens next depends on whether the assembly's votes on increased dues and the pandemic treaty can generate enough momentum to sustain an institution that, for nearly 80 years, has tried to improve global health—and now must convince the world that it is worth saving.
Citas Notables
Literally millions will likely die needlessly on the current trajectory and the world's health ministers do not seem capable of a coherent response.— Matthew Kavanagh, Georgetown University Center for Global Health Policy and Politics
Two-point-one billion dollars is the equivalent of global military expenditure every eight hours. Two-point-one billion dollars is the price of one stealth bomber, to kill people.— Tedros Adhanom Ghebreyesus, WHO Director-General
La Conversación del Hearth Otra perspectiva de la historia
Why does the U.S. withdrawal matter so much? Couldn't other countries just make up the difference?
The U.S. wasn't just a donor—it was the largest donor, and its exit signals something deeper. When America steps back, other wealthy nations see an opening to reduce their own commitments. Europe is already pivoting money toward defense. It's not just about the dollars; it's about the message it sends about whether the world still believes in this kind of collective action.
Tedros compared the budget to military spending and tobacco advertising. Was that effective, or just rhetoric?
It's both. But it's also true. The comparison isn't arbitrary—it's asking people to confront what we actually value. Two-point-one billion sounds abstract until you realize it's less than what we spend on killing and less than what we spend on selling cigarettes. The question becomes harder to dodge.
The article mentions millions could die needlessly. Is that speculation or based on something concrete?
It's grounded in what happens when disease surveillance breaks down, when pandemic preparedness atrophies, when you can't respond quickly to outbreaks. These aren't hypothetical scenarios. We've seen what happens when systems fail. The expert saying it isn't being alarmist—he's reading the trajectory.
What about the pandemic treaty? Does it actually solve anything?
It could, but only if countries actually use it and if the U.S. eventually comes back into the fold. Right now it's a framework without teeth. No penalties for non-compliance. It's a statement of intent more than a binding commitment. Its real power depends on whether it becomes the foundation for something stronger.
Why is CitizenGo protesting? What's their actual concern?
They see WHO as overreach—a centralized authority making decisions that should stay local or national. COVID amplified those fears. Whether you agree with them or not, they're expressing a real tension: how much power should global health institutions have, and who decides? That tension isn't going away.